trending Market Intelligence /marketintelligence/en/news-insights/trending/UXJgAZBkA2f05TOVNfLmSA2 content esgSubNav
In This List

Acasti Pharma falls out of compliance with Nasdaq listing requirement

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Acasti Pharma falls out of compliance with Nasdaq listing requirement

Canada's Acasti Pharma Inc. said it was no longer in compliance with Nasdaq's $1 minimum bid price listing requirement.

The drugmaker has until June 24, with a possibly of extension, to regain compliance.

The development has no immediate effect on Acasti's listing. The company said it will evaluate all available options to resolve the deficiency.